top of page

Nobel laureate Carolyn Bertozzi and Acepodia Co-Founder Sonny Hsiao on the science of antibody-cell conjugates

Dr. Bertozzi and Dr. Hsiao describe how Acepodia is leveraging biorthogonal chemistry to conjugate antibodies to allogeneic γδ2 T cells as a treatment for cancer.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page